2023-07-27 16:05:49 ET
- DexCom press release ( NASDAQ: DXCM ): Q2 Non-GAAP EPS of $0.34 beats by $0.11 .
- Revenue of $871.3M (+25.2% Y/Y) beats by $30.35M .
- U.S. revenue growth of 21% and international revenue growth of 38% on a reported basis. International revenue growth was 40% on an organic 1 basis.
- 2023 Outlook: Revenue of approximately $3.500 - 3.550 billion (20-22% growth)
- Non-GAAP Gross Profit Margin of approximately 63%
- Non-GAAP Operating Margin of approximately 17%
- Adjusted EBITDA Margin of approximately 26.5%.
- Shares +4.36% .
For further details see:
DexCom Non-GAAP EPS of $0.34 beats by $0.11, revenue of $871.3M beats by $30.35M